Federal Register notice: FDA announces a 1/23/24/2024 public meeting entitled Advancing Drug Development for the Prevention of Spontaneous Preterm Bir...
Federal Register final rule: FDA posts a final rule on direct-to-consumer advertisements and a requirement that the major statement must be presented ...
FDA publishes a draft guidance with questions and answers on translating GLP study reports into English.
Four stakeholders differ on an FDA draft guidance suggesting a new approach to biosimilar labeling on interchangeability.
FDA warns Cipla about CGMP and other violations at its Madhya Pradesh, India-based drug manufacturing facility.
SoClean recalls its SoClean2 and SoClean3 equipment that is used to clean, sanitize, or disinfect CPAP sleep apnea devices and accessories.
Three Epstein Becker Green attorneys analyze a new FDA draft guidance on communicating scientific information on unapproved uses of medical products.
FDA warns Dr. Melanie Hoppers/Physicians Quality Care in Jackson, TN, about violations in two clinical investigations at her study site.
